PALANTIR TECHNOLOGIES INC-A (PTX.DE) Fundamental Analysis & Valuation

FRA:PTX • US69608A1088

129.64 EUR
-0.9 (-0.69%)
Last: Mar 11, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This PTX.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

PTX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 121 industry peers in the Software industry. PTX gets an excellent profitability rating and is at the same time showing great financial health properties. PTX is valued quite expensively, but it does show have an excellent growth rating. These ratings could make PTX a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. PTX.DE Profitability Analysis

1.1 Basic Checks

  • PTX had positive earnings in the past year.
  • In the past year PTX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PTX reported negative net income in multiple years.
  • PTX had a positive operating cash flow in each of the past 5 years.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • The Return On Assets of PTX (18.26%) is better than 90.08% of its industry peers.
  • PTX has a better Return On Equity (22.00%) than 75.21% of its industry peers.
  • PTX has a better Return On Invested Capital (12.89%) than 76.03% of its industry peers.
  • PTX had an Average Return On Invested Capital over the past 3 years of 6.40%. This is significantly below the industry average of 13.12%.
  • The 3 year average ROIC (6.40%) for PTX is below the current ROIC(12.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROIC 12.89%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • PTX has a Profit Margin of 36.31%. This is amongst the best in the industry. PTX outperforms 91.74% of its industry peers.
  • PTX's Operating Margin of 31.59% is amongst the best of the industry. PTX outperforms 87.60% of its industry peers.
  • PTX has a better Gross Margin (82.37%) than 68.59% of its industry peers.
  • In the last couple of years the Gross Margin of PTX has grown nicely.
Industry RankSector Rank
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. PTX.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PTX is still creating some value.
  • The number of shares outstanding for PTX has been increased compared to 1 year ago.
  • PTX has more shares outstanding than it did 5 years ago.
  • PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • PTX has an Altman-Z score of 145.49. This indicates that PTX is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 145.49, PTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • There is no outstanding debt for PTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 145.49
ROIC/WACC1.18
WACC10.92%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • PTX has a Current Ratio of 7.11. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
  • PTX's Current ratio of 7.11 is amongst the best of the industry. PTX outperforms 93.39% of its industry peers.
  • PTX has a Quick Ratio of 7.11. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
  • PTX has a Quick ratio of 7.11. This is amongst the best in the industry. PTX outperforms 93.39% of its industry peers.
Industry RankSector Rank
Current Ratio 7.11
Quick Ratio 7.11
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

10

3. PTX.DE Growth Analysis

3.1 Past

  • PTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.93%, which is quite impressive.
  • Measured over the past years, PTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 132.08% on average per year.
  • Looking at the last year, PTX shows a very strong growth in Revenue. The Revenue has grown by 56.18%.
  • Measured over the past years, PTX shows a very strong growth in Revenue. The Revenue has been growing by 32.58% on average per year.
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%

3.2 Future

  • PTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.40% yearly.
  • PTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.23% yearly.
EPS Next Y78.65%
EPS Next 2Y58.72%
EPS Next 3Y53.49%
EPS Next 5Y53.4%
Revenue Next Year65.05%
Revenue Next 2Y53.44%
Revenue Next 3Y49.97%
Revenue Next 5Y49.23%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. PTX.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 202.56, the valuation of PTX can be described as expensive.
  • PTX's Price/Earnings ratio is a bit more expensive when compared to the industry. PTX is more expensive than 63.64% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, PTX is valued quite expensively.
  • With a Price/Forward Earnings ratio of 112.63, PTX can be considered very expensive at the moment.
  • PTX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PTX is more expensive than 68.59% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of PTX to the average of the S&P500 Index (24.39), we can say PTX is valued expensively.
Industry RankSector Rank
PE 202.56
Fwd PE 112.63
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • 73.55% of the companies in the same industry are cheaper than PTX, based on the Enterprise Value to EBITDA ratio.
  • 62.81% of the companies in the same industry are cheaper than PTX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 171.75
EV/EBITDA 243.28
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of PTX may justify a higher PE ratio.
  • A more expensive valuation may be justified as PTX's earnings are expected to grow with 53.49% in the coming years.
PEG (NY)2.58
PEG (5Y)N/A
EPS Next 2Y58.72%
EPS Next 3Y53.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PTX.DE Dividend Analysis

5.1 Amount

  • PTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PTX.DE Fundamentals: All Metrics, Ratios and Statistics

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (3/11/2026, 5:29:51 PM)

129.64

-0.9 (-0.69%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-02
Earnings (Next)05-04
Inst Owners61.62%
Inst Owner ChangeN/A
Ins Owners3.53%
Ins Owner ChangeN/A
Market Cap309.93B
Revenue(TTM)4.48B
Net Income(TTM)1.63B
Analysts75.88
Price Target163.84 (26.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.36%
Min EPS beat(2)6.45%
Max EPS beat(2)22.26%
EPS beat(4)3
Avg EPS beat(4)10.5%
Min EPS beat(4)-0.58%
Max EPS beat(4)22.26%
EPS beat(8)7
Avg EPS beat(8)10.39%
EPS beat(12)10
Avg EPS beat(12)10.73%
EPS beat(16)11
Avg EPS beat(16)-2.66%
Revenue beat(2)2
Avg Revenue beat(2)5.12%
Min Revenue beat(2)4.21%
Max Revenue beat(2)6.02%
Revenue beat(4)4
Avg Revenue beat(4)3.84%
Min Revenue beat(4)0.43%
Max Revenue beat(4)6.02%
Revenue beat(8)7
Avg Revenue beat(8)2.81%
Revenue beat(12)8
Avg Revenue beat(12)1.65%
Revenue beat(16)8
Avg Revenue beat(16)0.99%
PT rev (1m)-0.44%
PT rev (3m)0.95%
EPS NQ rev (1m)22.43%
EPS NQ rev (3m)36.01%
EPS NY rev (1m)20.04%
EPS NY rev (3m)30.07%
Revenue NQ rev (1m)10.42%
Revenue NQ rev (3m)16.74%
Revenue NY rev (1m)11%
Revenue NY rev (3m)15.72%
Valuation
Industry RankSector Rank
PE 202.56
Fwd PE 112.63
P/S 80.61
P/FCF 171.75
P/OCF 169.03
P/B 48.84
P/tB 48.84
EV/EBITDA 243.28
EPS(TTM)0.64
EY0.49%
EPS(NY)1.15
Fwd EY0.89%
FCF(TTM)0.75
FCFY0.58%
OCF(TTM)0.77
OCFY0.59%
SpS1.61
BVpS2.65
TBVpS2.65
PEG (NY)2.58
PEG (5Y)N/A
Graham Number6.18
Profitability
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROCE 18.3%
ROIC 12.89%
ROICexc 181.73%
ROICexgc 181.73%
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
FCFM 46.94%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)151.52%
ROICexc(5y)N/A
ROICexgc(3y)172.69%
ROICexgc(5y)N/A
ROCE(3y)9.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.59%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 148.21%
Profit Quality 129.26%
Current Ratio 7.11
Quick Ratio 7.11
Altman-Z 145.49
F-Score8
WACC10.92%
ROIC/WACC1.18
Cap/Depr(3y)71.63%
Cap/Depr(5y)95.48%
Cap/Sales(3y)0.63%
Cap/Sales(5y)0.96%
Profit Quality(3y)236.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y78.65%
EPS Next 2Y58.72%
EPS Next 3Y53.49%
EPS Next 5Y53.4%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%
Revenue Next Year65.05%
Revenue Next 2Y53.44%
Revenue Next 3Y49.97%
Revenue Next 5Y49.23%
EBIT growth 1Y355.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.32%
EBIT Next 3Y57.69%
EBIT Next 5Y2.83%
FCF growth 1Y84.06%
FCF growth 3Y125.29%
FCF growth 5YN/A
OCF growth 1Y84.98%
OCF growth 3Y112.09%
OCF growth 5YN/A

PALANTIR TECHNOLOGIES INC-A / PTX.DE FAQ

What is the ChartMill fundamental rating of PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PTX.DE.


What is the valuation status for PTX stock?

ChartMill assigns a valuation rating of 1 / 10 to PALANTIR TECHNOLOGIES INC-A (PTX.DE). This can be considered as Overvalued.


How profitable is PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

PALANTIR TECHNOLOGIES INC-A (PTX.DE) has a profitability rating of 7 / 10.


How financially healthy is PALANTIR TECHNOLOGIES INC-A?

The financial health rating of PALANTIR TECHNOLOGIES INC-A (PTX.DE) is 9 / 10.